# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-038868
Filing Date
2024-04-01
Accepted
2024-04-01 07:30:36
Documents
82
Period of Report
2023-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K | tcrt-20231231.htm iXBRL | 10-K | 2315802
2 | EX-10.59 | tcrt-ex10_59.htm | EX-10.59 | 47798
3 | EX-10.60 | tcrt-ex10_60.htm | EX-10.60 | 85653
4 | EX-10.61 | tcrt-ex10_61.htm | EX-10.61 | 50600
5 | EX-10.62 | tcrt-ex10_62.htm | EX-10.62 | 77943
6 | EX-23.1 | tcrt-ex23_1.htm | EX-23.1 | 3823
7 | EX-31.1 | tcrt-ex31_1.htm | EX-31.1 | 13371
8 | EX-32.1 | tcrt-ex32_1.htm | EX-32.1 | 7312
9 | EX-97.1 | tcrt-ex97_1.htm | EX-97.1 | 37870
10 | GRAPHIC | img160836378_0.jpg | GRAPHIC | 15323
11 | GRAPHIC | img160836378_1.jpg | GRAPHIC | 42879
12 | GRAPHIC | img160836378_2.jpg | GRAPHIC | 361119
| Complete submission text file | 0000950170-24-038868.txt |  | 10458053

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
13 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | tcrt-20231231.xsd | EX-101.SCH | 1523167
85 | EXTRACTED XBRL INSTANCE DOCUMENT | tcrt-20231231_htm.xml | XML | 1264571

Mailing Address 2617 BISSONNET ST SUITE 225 HOUSTON TX 77005
Business Address 2617 BISSONNET ST SUITE 225 HOUSTON TX 77005 (346) 355-4099
Alaunos Therapeutics, Inc. (Filer) CIK: 0001107421 (see all company filings)

EIN.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33038 | Film No.: 24805539
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)